Mingxing Zhang
Shanghai, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A Near-Infrared Fluorescent Probe for Specific Imaging of Lymph Node Metastases in Ovarian Cancer via Active Targeting of the Gonadotropin-Releasing Hormone Receptor.
Journal: Biomolecules
Published: May 05, 2025
The Classification, Prenatal Diagnosis and Perinatal Treatment of Fetal Lingual Lesions.
Journal: Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
Published: April 06, 2025
Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 14, 2024
Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 28, 2023
Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer.
Journal: Journal of ovarian research
Published: September 11, 2023
A follicle-stimulating hormone receptor-targeted near-infrared fluorescent probe for tumor-selective imaging and photothermal therapy.
Journal: Materials today. Bio
Published: September 05, 2023
Targeted Imaging of Endometriosis and Image-Guided Resection of Lesions Using Gonadotropin-Releasing Hormone Analogue-Modified Indocyanine Green.
Journal: Molecular imaging
Published: May 30, 2023
Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
Journal: Journal for immunotherapy of cancer
Published: February 16, 2022
Clinical analysis of uterine intravenous leiomyomatosis: A retrospective study of 260 cases.
Journal: The journal of obstetrics and gynaecology research
Published: May 20, 2021
A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
Journal: Bioengineered
Published: May 14, 2021
Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
Journal: Journal of nanobiotechnology
Published: June 24, 2020
Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.
Journal: Drug delivery
Published: April 19, 2018
Last Updated: 09/26/2026